{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:16:07Z","timestamp":1792498567424,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00231","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T05:55:47Z","timestamp":1583819747000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study"],"prefix":"10.3389","volume":"11","author":[{"given":"Jialing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zena","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zetao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieruo","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/ard.54.7.544","article-title":"Ankylosing spondylitis, IgA, and transforming growth factors.","volume":"54","author":"Archer","year":"1995","journal-title":"Ann. Rheum. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2018-214388","article-title":"Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study.","volume":"78","author":"Avina-Zubieta","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-017-0006-3","article-title":"Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF-RANKL signaling.","volume":"6","author":"Bartelt","year":"2018","journal-title":"Bone Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1182\/blood-2003-11-4085","article-title":"The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.","volume":"104","author":"Brouwer","year":"2004","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/1756-185X.12779","article-title":"The ongoing quest for biomarkers in Ankylosing Spondylitis.","volume":"18","author":"Danve","year":"2015","journal-title":"Int. J. Rheum. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/art.24838","article-title":"Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.","volume":"61","author":"de Vries","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M111.013904","article-title":"Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.","volume":"11","author":"Fischer","year":"2012","journal-title":"Mol. Cell Proteom."},{"key":"B8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1136\/annrheumdis-2013-204009","article-title":"Antitumour necrosis factor \u03b1 treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients.","volume":"73","author":"Genre","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01731","article-title":"The coagulation factors fibrinogen, thrombin, and factor XII in inflammatory disorders-a systematic review.","volume":"9","author":"Gobel","year":"2018","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jbspin.2015.07.008","article-title":"Molecular mechanisms of bone formation in spondyloarthritis.","volume":"83","author":"Gonzalez-Chavez","year":"2016","journal-title":"Joint Bone Spine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/ard.2004.023176","article-title":"Open label trial of anakinra in active ankylosing spondylitis over 24 weeks.","volume":"64","author":"Haibel","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00418-012-1062-9","article-title":"Retinol-binding protein 4 is expressed in chondrocytes of developing mouse long bones: implications for a local role in formation of the secondary ossification center.","volume":"139","author":"Hatfield","year":"2012","journal-title":"Histochem. Cell Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1530\/EJE-07-0796","article-title":"Retinol, retinol-binding protein 4, abdominal fat mass, peak bone mineral density, and markers of bone metabolism in men: the Northern Osteoporosis and Obesity (NO2) Study.","volume":"158","author":"Hogstrom","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.3760\/cma.j.issn.0366-6999.20131510","article-title":"Influence of sinomenine on protein profiles of peripheral blood mononuclear cells from ankylosing spondylitis patients: a pharmacoproteomics study.","volume":"126","author":"Huang","year":"2013","journal-title":"Chin. Med. J."},{"key":"B15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3349\/ymj.2007.48.2.218","article-title":"Serum amyloid a as a useful indicator of disease activity in patients with ankylosing spondylitis.","volume":"48","author":"Jung","year":"2007","journal-title":"Yonsei Med. J."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/cc9285","article-title":"Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation.","volume":"14","author":"Koch","year":"2010","journal-title":"Crit. Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1007\/s00296-011-1981-0","article-title":"Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy.","volume":"32","author":"Kwon","year":"2012","journal-title":"Rheumatol. Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s002960050114","article-title":"Serum amyloid A: an indicator of inflammation in ankylosing spondylitis.","volume":"19","author":"Lange","year":"2000","journal-title":"Rheumatol. Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1042\/bj2400529","article-title":"Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.","volume":"240","author":"Lerner","year":"1986","journal-title":"Biochem. J."},{"key":"B20","first-page":"201","article-title":"Serum disease-associated proteins of ankylosing spondylitis: results of a preliminary study by comparative proteomics.","volume":"28","author":"Li","year":"","journal-title":"Clin. Exp. Rheumatol."},{"key":"B21","first-page":"828","article-title":"Over-expression of talin 1 and integrin-linked kinase in PBMCs of patients with ankylosing spondylitis: a proteomic study.","volume":"28","author":"Li","year":"","journal-title":"Clin. Exp. Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.rdc.2012.08.003","article-title":"Pathophysiology of new bone formation and ankylosis in spondyloarthritis.","volume":"38","author":"Lories","year":"2012","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"B23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores.","volume":"70","author":"Machado","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","article-title":"TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss clinical quality management cohort.","volume":"77","author":"Molnar","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/nejmoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor a.","volume":"346","author":"Orman","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B26","first-page":"2457","article-title":"Retinol (vitamin A) and retinol-binding protein levels are decreased inankylosing spondylitis: clinical and genetic analysis.","volume":"34","author":"O\u2019Shea","year":"2007","journal-title":"J. Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/ard.2010.138883","article-title":"ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFalpha inhibitors.","volume":"70","author":"Pedersen","year":"","journal-title":"Ann. Rheum. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1002\/art.30627","article-title":"Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor alpha inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.","volume":"63","author":"Pedersen","year":"","journal-title":"Arthritis Rheum."},{"key":"B29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jdv.13005","article-title":"Anti-TNF-a therapy reduces retinol-binding protein 4 serum levels in non-diabetic patients with psoriasis: a 6-month prospective study.","volume":"30","author":"Pina","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/icb.2015.77","article-title":"TLR3 drives IRF6-dependent IL-23p19 expression and p19\/EBI3 heterodimer formation in keratinocytes.","volume":"93","author":"Ramnath","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","article-title":"Pathogenesis of ankylosing spondylitis - recent advances and future directions.","volume":"13","author":"Ranganathan","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00403-012-1306-5","article-title":"Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI.","volume":"305","author":"Romani","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0140-6736(16)31591-4","article-title":"Axial spondyloarthritis.","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1021\/pr800389e","article-title":"Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.","volume":"8","author":"Siu","year":"2009","journal-title":"J. Proteome Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis.","volume":"374","author":"Taurog","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1210\/me.2003-0061","article-title":"Liver X receptor signaling pathways in cardiovascular disease.","volume":"17","author":"Tontonoz","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for Ankylosing Spondylitis. A proposal for modification ofthe New York criteria.","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"B38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/ard.2007.084426","article-title":"Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis.","volume":"68","author":"Visvanathan","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.cca.2015.06.023","article-title":"MMPs and ADAMTSs in intervertebral disc degeneration.","volume":"448","author":"Wang","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M9.00384","article-title":"Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.","volume":"11","author":"Wright","year":"2012","journal-title":"Mol. Cell Proteom."},{"key":"B41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jprot.2014.09.014","article-title":"Up-regulation of fatty acid oxidation in the ligament as a contributing factor of ankylosing spondylitis: a comparative proteomic study.","volume":"113","author":"Xu","year":"2015","journal-title":"J. Proteom."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00231\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T22:06:46Z","timestamp":1722550006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00231\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":41,"alternative-id":["10.3389\/fphar.2020.00231"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00231","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"article-number":"231"}}